Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Alkermes plc - Ordinary Shares (NQ:ALKS)

27.83 -0.17 (-0.61%)
Streaming Delayed Price Updated: 12:10 PM EDT, Mar 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Alkermes plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Alkermes Stock Jumps Nearly 30% In 3 Months Amid Hefty Profits ↗
Alkermes develops treatments for neurodegenerative diseases (conditions that damage and destroy parts of the nervous system) and cancer. 
Via Investor's Business Daily
News headline image
Decoding 7 Analyst Evaluations For Alkermes ↗
 
Via Benzinga
News headline image
Despite its impressive fundamentals, NASDAQ:ALKS remains undervalued. ↗
ALKERMES PLC (NASDAQ:ALKS) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. 
Via Chartmill
News headline image
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗
 
Via Benzinga
News headline image
NASDAQ:ALKS: good value for what you're paying. ↗
For those who appreciate value investing, ALKERMES PLC (NASDAQ:ALKS) is a compelling option with its solid fundamentals. 
Via Chartmill
News headline image
Despite its impressive fundamentals, NASDAQ:ALKS remains undervalued. ↗
For those who appreciate value investing, ALKERMES PLC (NASDAQ:ALKS) is a compelling option with its solid fundamentals. 
Via Chartmill
News headline image
6 Analysts Assess Alkermes: What You Need To Know ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 7 Takes On Alkermes ↗
 
Via Benzinga
News headline image
6 Analysts Assess Alkermes: What You Need To Know ↗
 
Via Benzinga
News headline image
7 Analysts Assess Alkermes: What You Need To Know ↗
 
Via Benzinga
News headline image
NASDAQ:ALKS stands out as a stock that provides good value for the fundamentals it showcases. ↗
Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents. 
Via Chartmill
News headline image
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
ALKS Stock Earnings: Alkermes Beats EPS, Beats Revenue for Q2 2024 ↗
ALKS stock results show that Alkermes beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Exploring growth characteristics of ALKERMES PLC (NASDAQ:ALKS). ↗
Should you consider ALKERMES PLC (NASDAQ:ALKS) for growth investing? 
Via Chartmill
News headline image
Exploring growth characteristics of ALKERMES PLC (NASDAQ:ALKS). ↗
ALKERMES PLC (NASDAQ:ALKS) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
News headline image
Breaking Down Alkermes: 5 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
"Rule Breaker Investing" Stock Pick Review: The Big One ↗
Looking back at 30 five-stock samplers picked from 2015 to 2021. 
Via The Motley Fool
News headline image
NASDAQ:ALKS is an undervalued gem with solid fundamentals. ↗
Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents. 
Via Chartmill
News headline image
When you look at NASDAQ:ALKS, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. ↗
Don't overlook ALKERMES PLC (NASDAQ:ALKS)—it's a hidden gem with strong fundamentals and an attractive price tag. 
Via Chartmill
News headline image
Is NASDAQ:ALKS suited for growth investing? ↗
Is ALKERMES PLC (NASDAQ:ALKS) suited for growth investing? 
Via Chartmill
News headline image
The Analyst Verdict: Alkermes In The Eyes Of 4 Experts ↗
 
Via Benzinga
News headline image
In a market where value is scarce, NASDAQ:ALKS offers a refreshing opportunity with its solid fundamentals. ↗
Don't overlook ALKERMES PLC (NASDAQ:ALKS)—it's a hidden gem with strong fundamentals and an attractive price tag. 
Via Chartmill
News headline image
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition ↗
Investors should take a close look at these biotech stocks as they position themselves to provide high returns. 
Via InvestorPlace
News headline image
Investors should take notice of NASDAQ:ALKS—it offers a great deal for the fundamentals it presents. ↗
ALKERMES PLC (NASDAQ:ALKS) is probably undervalued for the fundamentals it is displaying. 
Via Chartmill
News headline image
ALKS Stock Earnings: Alkermes Misses EPS, Misses Revenue for Q1 2024 ↗
ALKS stock results show that Alkermes missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Investors should take notice of NASDAQ:ALKS—it offers a great deal for the fundamentals it presents. ↗
Don't overlook ALKERMES PLC (NASDAQ:ALKS)—it's a hidden gem with strong fundamentals and an attractive price tag. 
Via Chartmill
News headline image
Alkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst Says ↗
ALKS 2680 reports positive results in narcolepsy & idiopathic hypersomnia study. Statistically significant improvements in sleep latency were observed across all doses tested. Phase 2 study for NT2... 
Via Benzinga
News headline image
When you look at NASDAQ:ALKS, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. ↗
When you look at ALKERMES PLC (NASDAQ:ALKS), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. 
Via Chartmill
News headline image
A Look Into Healthcare Sector Value Stocks ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.